JP2017524727A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017524727A5 JP2017524727A5 JP2017514978A JP2017514978A JP2017524727A5 JP 2017524727 A5 JP2017524727 A5 JP 2017524727A5 JP 2017514978 A JP2017514978 A JP 2017514978A JP 2017514978 A JP2017514978 A JP 2017514978A JP 2017524727 A5 JP2017524727 A5 JP 2017524727A5
- Authority
- JP
- Japan
- Prior art keywords
- diabetic
- pharmaceutical composition
- sequence
- seq
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ESP201430796 | 2014-05-28 | ||
| ES201430796A ES2552587B1 (es) | 2014-05-28 | 2014-05-28 | Péptido derivado de socs1 para su uso en complicaciones crónicas de la diabetes |
| PCT/ES2015/070415 WO2015181427A1 (es) | 2014-05-28 | 2015-05-27 | Péptido derivado de socs1 para su uso en complicaciones crónicas de la diabetes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017524727A JP2017524727A (ja) | 2017-08-31 |
| JP2017524727A5 true JP2017524727A5 (enExample) | 2018-07-05 |
| JP6681387B2 JP6681387B2 (ja) | 2020-04-15 |
Family
ID=53546661
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017514978A Expired - Fee Related JP6681387B2 (ja) | 2014-05-28 | 2015-05-27 | 糖尿病の慢性合併症において使用するためのｓｏｃｓ１由来ペプチド |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10532082B2 (enExample) |
| EP (1) | EP3178485B1 (enExample) |
| JP (1) | JP6681387B2 (enExample) |
| CN (1) | CN107074922A (enExample) |
| BR (1) | BR112016027936A2 (enExample) |
| CA (1) | CA2950348A1 (enExample) |
| ES (2) | ES2552587B1 (enExample) |
| HU (1) | HUE041836T2 (enExample) |
| MX (1) | MX369378B (enExample) |
| PL (1) | PL3178485T3 (enExample) |
| PT (1) | PT3178485T (enExample) |
| TR (1) | TR201903509T4 (enExample) |
| WO (1) | WO2015181427A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2552587B1 (es) | 2014-05-28 | 2017-01-18 | Fundació Hospital Universitari Vall D'hebron-Institut De Recerca | Péptido derivado de socs1 para su uso en complicaciones crónicas de la diabetes |
| CN105315377A (zh) * | 2015-12-07 | 2016-02-10 | 华东理工大学 | 带有穿膜肽的tcs融合蛋白、质粒及制备方法与应用 |
| US20200206299A1 (en) * | 2016-02-23 | 2020-07-02 | Takeda Pharmaceutical Company Limited | Inhibitors of beta-arrestin-neurokinin 1 receptor interactions for the treatment of pain |
| CN106349347B (zh) * | 2016-10-25 | 2019-09-13 | 南通大学 | 一种小分子多肽、及其编码基因和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030175971A1 (en) * | 2001-12-28 | 2003-09-18 | Geoffrey Lindeman | Differentiation and/or proliferation modulating agents and uses therefor |
| WO2005086800A2 (en) * | 2004-03-04 | 2005-09-22 | Vanderbilt University | Cell-penetrating socs polypeptides that inhibit cytokine-induced signaling |
| EP1781338A4 (en) * | 2004-07-19 | 2010-02-10 | Baylor College Medicine | MODULATION OF CYTOKIN SIGNALING REGULATORS AND APPLICATIONS FOR IMMUNOTHERAPY |
| US20090030179A1 (en) | 2005-02-15 | 2009-01-29 | Toagosei Co., Ltd | Antimicrobial peptide and use thereof |
| WO2007010989A1 (ja) | 2005-07-20 | 2007-01-25 | Toagosei Co., Ltd. | 神経分化誘導ペプチド及びその利用 |
| WO2010151495A2 (en) | 2009-06-26 | 2010-12-29 | University Of Florida Research Foundation Inc. | Materials and methods for treating and preventing viral infections |
| WO2011113048A2 (en) * | 2010-03-12 | 2011-09-15 | Vanderbilt University | Modulation of cytokine signaling |
| CN102921007B (zh) * | 2011-08-09 | 2014-12-10 | 中国科学院上海生命科学研究院 | 防治胰岛素抵抗和糖尿病的方法和试剂 |
| CN103173446A (zh) * | 2011-12-26 | 2013-06-26 | 吕成伟 | 一种靶向干扰socs1基因的重组腺相关病毒载体的构建方法与应用 |
| ES2552587B1 (es) | 2014-05-28 | 2017-01-18 | Fundació Hospital Universitari Vall D'hebron-Institut De Recerca | Péptido derivado de socs1 para su uso en complicaciones crónicas de la diabetes |
-
2014
- 2014-05-28 ES ES201430796A patent/ES2552587B1/es not_active Expired - Fee Related
-
2015
- 2015-05-27 ES ES15738128T patent/ES2715412T3/es active Active
- 2015-05-27 MX MX2016015514A patent/MX369378B/es active IP Right Grant
- 2015-05-27 JP JP2017514978A patent/JP6681387B2/ja not_active Expired - Fee Related
- 2015-05-27 BR BR112016027936A patent/BR112016027936A2/pt not_active IP Right Cessation
- 2015-05-27 HU HUE15738128A patent/HUE041836T2/hu unknown
- 2015-05-27 WO PCT/ES2015/070415 patent/WO2015181427A1/es not_active Ceased
- 2015-05-27 US US15/314,395 patent/US10532082B2/en active Active
- 2015-05-27 EP EP15738128.6A patent/EP3178485B1/en active Active
- 2015-05-27 PT PT15738128T patent/PT3178485T/pt unknown
- 2015-05-27 PL PL15738128T patent/PL3178485T3/pl unknown
- 2015-05-27 CN CN201580040669.6A patent/CN107074922A/zh active Pending
- 2015-05-27 CA CA2950348A patent/CA2950348A1/en not_active Abandoned
- 2015-05-27 TR TR2019/03509T patent/TR201903509T4/tr unknown
-
2019
- 2019-11-20 US US16/689,924 patent/US20200138903A1/en not_active Abandoned